Posts for the 'Digitek' Category
Digoxin Recall Lawyers: Another Generic Poses Risk of Digoxin Toxicity
The lawyers at Saiontz & Kirk, P.A. have been investigating potential Digitek recall lawsuits for nearly a year on behalf of individuals who suffered digoxin toxicity after receiving oversized tablets. Now another generic drug maker has issued a digoxin recall involving pills that may contain too much of the medication, posing a similar risk of serious injury or death.
Digitek Wrongful Death Lawsuits
The attorneys at Saiontz & Kirk, P.A. have been investigating potential Digitek lawsuits since the generic heart drug was recalled in April 2008. Although Actavis has attempted to argue that none of the oversized tablets ever reached the public, according to reports of adverse events submitted to the FDA, there have been at least 667 Digitek deaths reported where the drug was identified as the “primary suspect.”
Digoxin Recall Leads to Congressional Inquiry
Following a series of recalls issued by Actavis this year, including a digoxin recall for all lots of their Digitek heart medication in May 2008, the U.S. House Committee on Energy and Commerce has requested additional information from the FDA about their oversight of the drug maker. This inquiry is part of a continuing investigation by the Committee into the ability of the FDA to protect Americans from dangerous prescription drugs, food products and medical devices.
Digoxin Lawsuit Consolidation in West Virginia
Last week the United States Judicial Panel on Multidistrict Litigation ordered that any individual Digoxin lawsuit filed as a result of the April 2008 Digitek recall should be transferred to the Southern District of West Virginia. All cases will be consolidated for pretrial litigation and discovery before Judge Joseph R. Goodwin.
Following Digitek recall, Actavis issues recall for 65 other drugs made at same plant
On Monday, Actavis Totowa, LLC, the maker of Digitek, recalled over 65 different generic drugs made at their New Jersey manufacturing plant. Following an FDA inspection earlier this year, a number of violations of good manufacturing practices were identified. In April 2008, Actavis issued a Digitek recall for all lots of their generic digoxin which were made at the same plant, after they discovered that tablets had been commercially sold which were twice as thick as they were supposed to be.
>>PRIOR POST (5/4/2008): Digitek Recall Due to Risk of Digoxin Overdose
Digitek Overdose Lawsuits: Double strength tablets increased risk of digitalis toxicity
The lawyers at Saiontz & Kirk, P.A. are investigating potential Digitek overdose lawsuits for individuals who experienced digitalis toxicity resulting in severe injuries or the need for medical treatment. Manufacturing defects allowed certain Digitek (digoxin) tablets to be sold with twice the appropriate amount of ingredient, increasing the risk of a digoxin overdose.
Digitek lawsuits have been filed and more cases are coming
Less than two months after a Digitek recall was issued due to manufacturing problems that allowed double strength tablets to be commercially released, at least three lawsuits have been filed. A number of additional cases are expected to be filed in the coming weeks, as hundreds of potential cases are currently being investigated throughout the country by individuals who are trying to determine if they may be entitled to compensation through a Digitek lawsuit.
Ethex Morphine Recall due to risk of Morphine Overdose
A nationwide Ethex morphine recall was issued yesterdat for 60 mg extended release morphine sulfate tablets. It was discovered that certain pills sold may contain up to double the appropriate medication and be twice as thick as normal. The recall lawyers at Saiontz & Kirk, P.A. are reviewing potential Ethex morphine lawsuits for individuals who suffered a morphine overdose or death while taking the medication.
>>FDA LINK: Ethex Morphine Sulfate Recall
Extent of Digitek Problems remains unclear
It has been over three weeks since a nationwide Digitek recall was issued after it was discovered that some tablets could contain twice the appropriate strength. However, very little information has been released about the extent of the Digitek problems and exactly how long double strength tablets have been sold.
Digitek Class Action Lawsuits filed
Two weeks after a nationwide Digitek recall, several class action lawsuits have already been filed on behalf of users who took the heart drug. Manufacturing problems resulted in some tablets being sold with twice as much of the active medication as they were supposed to have. While Digitek class action suits are seeking reimbursement for the cost of the prescription medication and funding for medical monitoring, those who have suffered severe injuries or death after taking Digitek, should consider pursuing an individual lawsuit.
